Search for: "F. S. v. J. S." Results 2021 - 2040 of 8,310
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2019, 5:35 pm by INFORRM
Last Week in the Courts The trial in the case of Rudd v Bridle concluded before Warby J on 11 March 2019. [read post]
14 Mar 2019, 12:35 pm by Schachtman
(quoting Baer, J.). 8 See, e.g, Restatement (Third) of Torts: Products Liability § 2, and comment I (1998); Fane v. [read post]
12 Mar 2019, 10:38 am by Eugene Volokh
Stuart, 423 U.S. 1327, 1329 (1975) (Blackmun, J., in chambers); CBS, Inc. v. [read post]
12 Mar 2019, 6:49 am by Jonathan Holbrook
Jefferson, 911 F.3d 1290 (10th Cir., 2018) (affirming defendant’s robbery convictions, and noting that the “substantial” evidence of his guilt included not only surveillance videos and his admissions, but also a “Facebook post made after the January 9 robberies, which included a firearm emoji”);  Commonwealth v. [read post]
11 Mar 2019, 10:07 am
This was explained by Laddie J in Inhale v Quadrant 2002 RPC 21 at [47].... [read post]
10 Mar 2019, 4:00 am by Administrator
DROITS ET LIBERTÉS — droits et libertés fondamentaux — intégrité de la personne — dépendance à la nicotine — maladie — fumeur — responsabilité extracontractuelle — compagnies de tabac — risques et dangers de la cigarette — obligation de renseignement — atteinte illicite et intentionnelle — intégrité de la personne — droit à la vie, à… [read post]
5 Mar 2019, 2:08 am by Jessica Kroeze
Daher erscheint die Herbeiführung einer Entscheidung der Großen Beschwerdekammer als der am besten geeignete und daher gebotene Weg, die Grundfrage des richtigen Verhandlungsortes in Beschwerdeverfahren für alle Kammern und Fälle einheitlich zu beantworten.2. [read post]
4 Mar 2019, 8:44 am by Brian Cordery
Lilly v Genentech provided Arnold J will the opportunity to consider this issue in the context of two claims of Genentech’s patent to IL-17A/F antibodies. [read post]
1 Mar 2019, 5:47 am
However, the Arnold J nonetheless felt it necessarily to submit a reference to the CJEU on the question of the third party market authorization. [read post]